Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.
Sign Up to like & getrecommendations! Published in 2017 at "Clinical science"
DOI: 10.1042/cs20160545
Abstract: G-protein-coupled receptor 120 (GPR120) is a putative target for obesity and diabetes therapies. However, it remains controversial whether resident GPR120 plays a direct regulatory role in islet β-cell insulin secretion. The present study examined this… read more here.
Keywords: insulinotropic effects; expression; obese non; gpr120 ... See more keywords